CARISMA Therapeutics Stock Soars 112.33% in Pre-Market Trading

On June 10, 2025, CARISMA Therapeutics experienced a remarkable surge, with its stock price rising by 112.33% in pre-market trading.

CARISMA Therapeutics has seen significant volatility in recent trading sessions. The stock price gained 16.97% on the last trading day, rising from $0.194 to $0.227. This marks the third consecutive day of gains, with the stock price fluctuating 21.71% from a day low of $0.193 to a day high of $0.235. The stock has risen in 7 of the last 10 days and is up by 22.59% over the past two weeks. Volume has increased on the last day along with the price, which is a positive technical sign.

Despite the recent gains, the stock lies in the upper part of a very wide and falling trend in the short term. This may pose a good selling opportunity for short-term traders as a reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.233 will indicate a slower falling rate and may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -50.08% during the next three months.

Several short-term signals are positive, despite the stock being in a falling trend. The stock holds buy signals from both short and long-term Moving Averages, giving a positive forecast for the stock. However, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.193 and $0.199. A breakdown below any of these levels will issue sell signals.

For the upcoming trading day, the stock is expected to open at $0.218 and move between $0.204 and $0.250, giving a possible trading interval of +/-$0.0229 (+/-10.10%) up or down from the last closing price. Since the stock is closer to the resistance from accumulated volume at $0.231 than the support at $0.192, the trading risk/reward intra-day is not considered attractive.